Constitutive Single Nucleotide Polymorphisms (SNP) Assessment for Predicting Tolerability and Efficacy of Triplet Hepatic Artery Infusion (HAI) and Intravenous Cetuximab (IV-CET) in Patients (pts) with Liver Metastases from Colorectal Cancer (LM-CRC) (european Trial OPTILIV, NCT00852228).
Journal of Clinical Oncology(2014)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要